R
Ronald I. Clyman
Researcher at University of California, San Francisco
Publications - 244
Citations - 10651
Ronald I. Clyman is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Ductus arteriosus & Bronchopulmonary dysplasia. The author has an hindex of 58, co-authored 238 publications receiving 9750 citations. Previous affiliations of Ronald I. Clyman include National Institutes of Health & Syracuse University.
Papers
More filters
Journal ArticleDOI
Bronchopulmonary Dysplasia: Executive Summary of a Workshop.
Rosemary D. Higgins,Alan H. Jobe,Marion Koso-Thomas,Eduardo Bancalari,Rose M. Viscardi,Tina V. Hartert,Rita M. Ryan,Suhas G. Kallapur,Robin H. Steinhorn,Girija G. Konduri,Stephanie D. Davis,Bernard Thébaud,Ronald I. Clyman,Joseph M. Collaco,Camilia R. Martin,Jason C. Woods,Neil N. Finer,Tonse N.K. Raju +17 more
TL;DR: A workshop on bronchopulmonary dysplasia held in October 2016 developed a proposal for an updated definition for BPD based on prior definitions and current care practices and discussed a research agenda and the strengths and limitations of available management options.
Journal ArticleDOI
Neonatal Complications after the Administration of Indomethacin for Preterm Labor
TL;DR: There were no significant differences between the two groups in birth weight, Apgar scores, cord-blood gas values, frequency of multiple gestation, or incidence of respiratory distress syndrom...
Journal ArticleDOI
Mechanisms Regulating the Ductus Arteriosus
TL;DR: Comparison physiology between the full term and preterm newborn and the barriers preventing the necessary cascade of events leading to permanent constriction of the PDA are reviewed.
Journal ArticleDOI
Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?
TL;DR: New information suggests that early pharmacologic treatment has several important short-term benefits for the preterm newborn, and ductus ligation, while eliminating the detrimental effects of a PDA on lung development, may create its own set of morbidities that counteract many of the benefits derived from ductus closure.
Journal ArticleDOI
Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity.
TL;DR: Use of surgical ligation was significantly associated with the development of chronic lung disease and was independent of immature gestation, other patent ductus arteriosus–related variables, or other perinatal and neonatal risk factors known to be associated with Chronic lung disease.